MARATHON CAPITAL MANAGEMENT

Position in ADMA — Adma Biologics, Inc.

CIK 1213206 Hunt Valley, MD

Position in ADMA

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$4,455,794

-$1,196,971 QoQ

Shares Held

532,353

-15.1% QoQ

Ownership

0.238%

of shares outstanding

% of Portfolio

1.02%

of 13F equity value

Holder Rank

#56

of 323 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 7% Shared 0% None 93%

Healthcare · as of Jun 30, 2026

MARATHON CAPITAL MANAGEMENT holds $5,159,453 across 4 Biotechnology names. ADMA ranks #1 (86.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ADMA	Adma Biologics, Inc. This page	532,353	$4,455,794
2	RPRX	Royalty Pharma plc	9,364	$525,039
3	DYAI	Dyadic International Inc	110,000	$99,000
4	RXRX	Recursion Pharmaceuticals, Inc.	21,695	$79,620

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,455,794	532,353	-15.1%	Shares	Sole	2026-07-22
2026-03-31	$5,652,765	627,388	+34.8%	Shares	Sole	2026-05-14
2025-12-31	$8,487,345	465,315	-0.3%	Shares	Sole	2026-01-29
2025-09-30	$6,839,916	466,570	+64.5%	Shares	Sole	2025-11-14
2025-06-30	$5,165,994	283,690	+82.9%	Shares	Sole	2025-08-14
2025-03-31	$3,077,580	155,120	—	Shares	Sole	2025-05-15
No filing history on record for this holder in this stock.